Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Akebia Therapeutics, Inc. (AKBA)
Sector: Healthcare; Industry: Biotechnology

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-01 Faulkingham Dell SVP, CCO Sell 952 $3.40 $3,237 No
2021-04-01 Spellman David A SVP, CFO and Treasurer Sell 790 $3.40 $2,686 No
2021-04-01 Hadas Nicole R. SVP, Chief Legal Officer Sell 1,060 $3.40 $3,604 No
2021-04-01 Dahan Michel SVP, Chief Operating Officer Sell 1,211 $3.40 $4,117 No
2021-04-01 Butler John P. CEO and President Sell 4,109 $3.40 $13,971 No
2021-04-01 Burke Steven Keith SVP, Chief Medical Officer Sell 1,081 $3.40 $3,675 No
2021-03-01 Butler John P. CEO and President Sell 49,990 $3.40 $169,771 Yes
2021-03-01 Faulkingham Dell CCO Sell 6,749 $3.40 $22,920 Yes
2021-03-01 Dahan Michel SVP, Chief Operating Officer Sell 14,547 $3.40 $49,403 Yes
2021-03-01 Burke Steven Keith SVP, Chief Medical Officer Sell 7,558 $3.40 $25,668 Yes
2020-06-08 Smith Cynthia Director Sell 4,567 $12.10 $55,261 Yes
2020-06-08 GILMAN STEVEN C Director Sell 4,567 $12.08 $55,169 Yes
2020-06-08 GOWEN MAXINE Director Sell 4,567 $12.05 $55,032 Yes
2020-06-01 Faulkingham Dell CCO Sell 6,426 $11.58 $74,413 No
2020-02-28 Dahan Michel SVP, Chief Operating Officer Sell 6,972 $8.70 $60,656 Yes
2020-02-28 Hadas Nicole R. SVP, Chief Legal Officer Sell 7,050 $8.70 $61,335 Yes
2020-02-28 Amello Jason SVP, CFO & Treasurer Sell 6,976 $8.70 $60,691 Yes
2020-02-28 Tubridy Karen L SVP, Chief Development Officer Sell 3,454 $8.70 $30,050 Yes
2019-11-20 GILMAN STEVEN C Director Buy 5,800 $3.43 $19,894 No
2019-11-20 Smith Cynthia Director Buy 15,000 $3.52 $52,800 No
2019-11-20 Burke Steven Keith SVP, Chief Medical Officer Buy 27,000 $3.58 $96,660 No
2019-11-20 Butler John P. CEO and President Buy 50,000 $3.44 $172,000 No
2019-11-20 ADAMS ADRIAN Director Buy 50,000 $3.41 $170,500 No
2018-02-15 Nash Duane Director Sell 1,000 $14.62 $14,620 No
2017-10-02 Nash Duane Director Sell 1,188 $19.64 $23,332 No
2017-10-02 Hadas Nicole R. SVP, General Counsel, Sec. Sell 7,803 $19.89 $155,188 No
2017-10-02 Dahan Michel SVP, Chief Business Officer Sell 1,398 $19.64 $27,457 No
2017-09-28 Dahan Michel SVP, Chief Business Officer Sell 5,000 $19.30 $96,500 No
2017-08-15 Dahan Michel SVP, Chief Business Officer Sell 5,000 $15.00 $75,000 No
2017-07-05 Satter Muneer A Director Buy 1,034,482 $14.50 $14,999,989 No

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.